Duloxetine in the Treatment of Depression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Duloxetine in the Treatment of Depression

Published:2004-08 Issue:4 Volume:24 Page:389-399
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Goldstein David J.,Lu Yili,Detke Michael J.,Wiltse Curtis,Mallinckrodt Craig,Demitrack Mark A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference36 articles.

1. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?;Davidson;J Clin Psychiatry,1999

2. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.;Melfi;Arch Gen Psychiatry,1998

3. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.;Mace;Expert Opin Pharmacother,2000

4. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.;Thase;Br J Psychiatry,2001

5. Dual monoamine modulation for improved treatment of major depressive disorder.;Tran;J Clin Psychopharmacol,2003

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference‐Base Centred Multiple Imputation;Pharmaceutical Statistics;2024-07-16

2. Bayesian second-order sensitivity of longitudinal inferences to non-ignorability: an application to antidepressant clinical trial data;The International Journal of Biostatistics;2023-11-27

3. The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression;International Journal of Molecular Sciences;2023-08-30

4. Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential;Signal Transduction and Targeted Therapy;2023-08-30

5. A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder;Journal of Affective Disorders;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3